Neurocrine Biosciences NBIX
NASDAQ NBIX
$174.41 +5.27 (+3.12%)
At close: Nov 11, 2026 · 4:00 PM EST

Neurocrine Biosciences (NBIX) Total Current Liabilities (2009 - 2026)

Updated

Neurocrine Biosciences' Total Current Liabilities came in at $984.6 million for Q3 2026, up 54.3% from $638 million a year earlier and up 12.6% from the prior quarter.

Analysis

Neurocrine Biosciences (NBIX) Total Current Liabilities (2009 - 2026) Analysis & Trends

At the end of FY2025, Neurocrine Biosciences' Total Current Liabilities was $743.4 million, up 46.4% from FY2024.

  • Total Current Liabilities carries a five-year compound annual growth rate of 31.9% (FY2020 to FY2025).
  • Going back by year, Total Current Liabilities was $507.7 million in FY2024 (-22.5%), $654.8 million in FY2023 (+21.8%), $537.7 million in FY2022 (+118.8%) and $245.8 million in FY2021 (+31.8%).
  • The Q3 2026 figure represents the highest quarterly Total Current Liabilities in data going back to Q4 2010.
  • Year-over-year, Total Current Liabilities has increased for six consecutive quarters, with growth averaging 32.0% over the last eight quarters.
  • The fastest year-over-year change in Total Current Liabilities over five years came in Q4 2022 (growth of 118.8%), and the weakest in Q3 2024 (a decline of 37.9%).
  • Business Quant data shows NBIX's Total Current Liabilities at $874.5 million (Q2 2026), $831.7 million (Q1 2026) and $743.4 million (Q4 2025) in the three quarters before Q3 2026.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Total Current Liabilities (Qtr)
1 Eli Lilly 1,348.13 Bn 1,321.74 Bn 20.46 Bn 47.00 Bn
2 Johnson & Johnson 675.90 Bn 595.76 Bn 17.30 Bn 55.46 Bn
3 AbbVie 519.45 Bn 487.50 Bn 13.12 Bn 43.10 Bn
4 Merck 364.95 Bn 327.95 Bn 13.19 Bn 28.80 Bn
5 Novartis Ag 311.58 Bn 285.16 Bn - -
6 Astrazeneca 289.34 Bn 262.94 Bn 13.26 Bn -31.27 Bn
7 Amgen 251.64 Bn 203.30 Bn 7.58 Bn 23.23 Bn
8 Gilead Sciences 212.05 Bn 187.07 Bn 6.73 Bn 12.00 Bn
9 Pfizer 167.35 Bn 115.00 Bn 12.56 Bn 31.73 Bn
10 Neurocrine Biosciences 17.13 Bn 13.21 Bn 1.10 Bn 984.60 Mn
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2026 984.60 Mn
Jun 30, 2026 874.50 Mn
Mar 31, 2026 831.70 Mn
Dec 31, 2025 743.40 Mn
Sep 30, 2025 638.00 Mn
Jun 30, 2025 546.30 Mn
Mar 31, 2025 522.90 Mn
Dec 31, 2024 507.70 Mn
Sep 30, 2024 429.70 Mn
Jun 30, 2024 398.50 Mn
Mar 31, 2024 712.90 Mn
Dec 31, 2023 654.80 Mn
Sep 30, 2023 691.60 Mn
Jun 30, 2023 582.50 Mn
Mar 31, 2023 374.10 Mn
Dec 31, 2022 537.70 Mn
Sep 30, 2022 485.10 Mn
Jun 30, 2022 285.70 Mn
Mar 31, 2022 253.50 Mn
Dec 31, 2021 245.80 Mn
API Access

Neurocrine Biosciences Total Current Liabilities API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=total-current-liabilities&ticker=NBIX&period=max&api_key=YOUR_API_KEY